Skip to Main Content

Paper Details

Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network.
Am J Kidney Dis
2
2023
Children, Glomerulonephropathy, MCD, Minimal Change Disease, Minimal change disease, Patients, children, kidney failure, minimal change disease, nephrotic syndrome, participants, patients, renin, rituximab
Author NameAffiliation
Isabelle AyoubWexner Medical Center, The Ohio State University
Jeffrey B KoppNational Institute of Diabetes and Digestive and Kidney Diseases
David T SelewskiMedical University of South Carolina
Amy K MottlUniversity of North Carolina, and Duke Children's Hospital Medical Center
Debbie S Gipsonand University of Michigan ann arbor
  • 1 - 5

Datasets

Release 1.2